BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250916T090000
DTEND;TZID=America/Halifax:20250916T233000
DTSTAMP:20260415T022031
CREATED:20250811T093132Z
LAST-MODIFIED:20250811T093144Z
UID:10000240-1758013200-1758065400@oncodaily.com
SUMMARY:13th Annual Symposium on Global Cancer Research
DESCRIPTION:The 13th Annual Symposium on Global Cancer Research (ASGCR) will be held as a one-day virtual event on Tuesday\, September 16\, 2025\, from 9:00 AM to 11:30 AM U.S. Eastern Time. This symposium will feature key scientific content and presentations\, including the highest scoring oral abstracts\, the presentation of the annual Rachel Pearline Award\, and a keynote address. Registration for the event is free of charge. \nThe event is convened by the National Cancer Institute’s Center for Global Health\, with a diverse array of leaders and experts involved from global institutions and organizations focusing on cancer research\, clinical oncology\, advocacy\, and public health. \nThis symposium provides an important opportunity for global cancer researchers\, clinicians\, advocates\, and policymakers to share scientific discoveries and advances in cancer research with a global perspective. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRegistration is now open.
URL:https://oncodaily.com/event/global-cancer-research-345934
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/OncoDaily-17.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250319T000000
DTEND;TZID=America/Halifax:20250320T000000
DTSTAMP:20260415T022031
CREATED:20241020T202339Z
LAST-MODIFIED:20250608T090245Z
UID:10000050-1742342400-1742428800@oncodaily.com
SUMMARY:NCI Symposium on Translational Technologies for Global Health
DESCRIPTION:NCI Symposium on Translational Technologies for Global Health will be held from March 19-20\, 2025 at NIH Main Campus Natcher Auditorium. \nThis two-day conference will bring together researchers\, technology developers\, clinicians\, and industry partners from NCI-funded grants and contracts to advance and translate new and emerging technologies for global oncology. Participants will include regulatory administrators\, NGO leaders\, and a diverse range of stakeholders\, all focused on accelerating global health technology innovation\, validation\, and commercialization. \nThe agenda will feature plenary panels of ACTs investigators\, scientists from related programs\, industry stakeholders\, and notable figures from USG and global oncology organizations. Additionally\, a technology showcase will provide an opportunity for symposium participants to engage directly with the innovative technologies being developed within these programs. \nRegistration is open for the event.
URL:https://oncodaily.com/event/168512
LOCATION:NIH Main Campus Natcher Auditorium\, 9000 Rockville Pike Bethesda\, MD\, Bethesda\, 9000\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/GaL43-sW0Ac6ATP-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241210T093000
DTEND;TZID=America/Halifax:20241211T153000
DTSTAMP:20260415T022031
CREATED:20241209T142331Z
LAST-MODIFIED:20250608T081727Z
UID:10000099-1733823000-1733931000@oncodaily.com
SUMMARY:NCI Cancer Integrative Medicine Grantee Virtual Conference
DESCRIPTION:NCI Cancer Integrative Medicine Grantee Virtual Conference will be held from December 10-11\, 2024. \n\n\n\n\nThis open-to-the-public event\, with registration required\, will focus on the integration of conventional cancer treatments with complementary therapies to improve patient outcomes and quality of life. \nThe conference aims to achieve two main objectives: \n\nGrantsmanship: It will provide valuable learning opportunities regarding grantsmanship\, tools\, and resources from NCI/NIH\, while also allowing NCI program staff to hear directly from grantees about their needs and challenges.\nResearch: The event will showcase NCI/NIH-funded research on cancer-related complementary and integrative medicine. It will highlight key findings and identify gaps or needs for advancing translational and clinical research in integrative oncology\, especially in advancing precision medicine across the cancer continuum.\n\nThe conference will play a crucial role in advancing the understanding and practice of integrative oncology\, which combines standard cancer therapies with complementary methods such as acupuncture\, herbal medicine\, lifestyle changes\, and mind-body techniques. The goal is to enhance both the physical and emotional well-being of cancer patients\, improving overall therapeutic outcomes. \n\n\n\n\nRegistration is Open.
URL:https://oncodaily.com/event/200593
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/1733670025234-e1733753597281.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241023T000000
DTEND;TZID=Europe/Helsinki:20241025T000000
DTSTAMP:20260415T022031
CREATED:20241017T182233Z
LAST-MODIFIED:20250608T081055Z
UID:10000047-1729641600-1729814400@oncodaily.com
SUMMARY:36th EORTC-NCI-AACR Symposium
DESCRIPTION:36th EORTC-NCI-AACR Symposium will be held at Barcelona\, Spain from October 23-25\, 2024. \nHosted by the European Organisation for Research and Treatment of Cancer (EORTC)\, the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR)\, the 2024 Symposium attracts academics\, scientists and pharmaceutical industry representatives from across the globe to discuss the latest innovations in drug development\, target selection and the impact of new discoveries in molecular biology. \nENA 2024 stands as the drug development and translational research meeting\, giving the spotlight to preclinical and phase I studies\, ensuring in-depth scientific discussions on the latest developments in targets and drugs. \nFor Registration Visit Here
URL:https://oncodaily.com/event/166975
LOCATION:Centre de convencions internacional Bacerlona\, Plaça de Willy Brandt\, 11-14\, Barcelona\, 08019\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/ENA_900x400-1.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
END:VCALENDAR